Abstract 5607: Discovery and preclinical evaluation of a potent, orally bioavailable, highly selective, small molecule PTPN2/1 inhibitor
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: ChemDiv (United States), Molsoft (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409631124
